A detailed history of Bank Of America Corp transactions in Io Biotech, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,651,515 shares of IOBT stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,651,515
Previous 1,651,515 -0.0%
Holding current value
$1.5 Million
Previous $1.93 Million 10.25%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.17 - $1.71 $225,423 - $329,465
-192,670 Reduced 10.45%
1,651,515 $1.93 Million
Q4 2023

Feb 14, 2024

SELL
$0.84 - $1.95 $8,400 - $19,500
-10,000 Reduced 0.54%
1,844,185 $3.47 Million
Q4 2022

Feb 10, 2023

BUY
$2.22 - $3.1 $4.09 Million - $5.72 Million
1,844,185 Added 18441.85%
1,854,185 $4.26 Million
Q4 2021

Feb 08, 2022

BUY
$6.4 - $15.65 $64,000 - $156,500
10,000 New
10,000 $64,000

Others Institutions Holding IOBT

About IO Biotech, Inc.


  • Ticker IOBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,815,300
  • Market Cap $26.2M
  • Description
  • IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in ph...
More about IOBT
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.